NY-ESO-1-Specific CD8 T Cell Response in NY-ESO-1 Seropositive Metastatic Melanoma Patients Treated with Ipilimumab Correlates with Clinical Benefit

被引：0
|
作者：
Yuan, Jianda [1 ]
Gnjatic, Sacha [2 ]
Adamow, Matthew [1 ]
Ginsberg, Brian [1 ]
Rasalan, Teresa S. [1 ]
Ritter, Erika [2 ]
Gallardo, Humilidad F. [1 ]
Xu, Yinyan [1 ]
Pogoriler, Evelina [3 ]
Panageas, Katherine S. [3 ]
Yang, Arvin [1 ,3 ]
Terzulli, Stephanie [1 ,3 ]
Ritter, Gerd [2 ]
Old, Lloyd J. [2 ]
Allison, James P. [1 ]
Wolchok, Jedd D. [1 ,3 ]
机构：
[1] Ludwig Ctr Canc Immunotherapy, New York, NY USA
[2] Ludwig Inst Canc Res, NY Branch, New York, NY USA
[3] MSKCC, New York, NY USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2010年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：913 / 914
页数：2
相关论文
共 50 条
  • [41] NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC
    Takeoka, Tomohira
    Nagase, Hirotsugu
    Kurose, Koji
    Ohue, Yoshihiro
    Yamasaki, Makoto
    Takiguchi, Shuji
    Sato, Eiichi
    Isobe, Midori
    Kanazawa, Takayuki
    Matsumoto, Mitsunobu
    Iwahori, Kota
    Kawashima, Atsunari
    Morimoto-Okazawa, Akiko
    Nishikawa, Hiroyoshi
    Oka, Mikio
    Pan, Linda
    Venhaus, Ralph
    Nakayama, Eiichi
    Mori, Masaki
    Doki, Yuichiro
    Wada, Hisashi
    JOURNAL OF IMMUNOTHERAPY, 2017, 40 (04) : 140 - 147
  • [42] Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naive and memory NY-ESO1-specific CD8+ T cells
    Masterman, Kelly-Anne
    Haigh, Oscar L.
    Tullett, Kirsteen M.
    Leal-Rojas, Ingrid M.
    Walpole, Carina
    Pearson, Frances E.
    Cebon, Jonathon
    Schmidt, Christopher
    O'Brien, Liam
    Rosendahl, Nikita
    Daraj, Ghazal
    Caminschi, Irina
    Gschweng, Eric H.
    Hollis, Roger P.
    Kohn, Donald B.
    Lahoud, Mireille H.
    Radford, Kristen J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [43] Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination
    Karbach, Julia
    Gnjatic, Sacha
    Pauligk, Claudia
    Bender, Armin
    Maeurer, Markus
    Schultze, Joachim L.
    Nadler, Kerstin
    Wahle, Claudia
    Knuth, Alexander
    Old, Lloyd J.
    Jaeger, Elke
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (09) : 2042 - 2048
  • [44] NY-ESO-1 Vaccination in Combination with Decitabine for Patients with MDS Induces CD4+and CD8+T-Cell Responses
    Srivastava, Pragya
    Matsuzaki, Junko
    Paluch, Benjamin E.
    Brumberger, Zachary
    Kaufman, Stephanie
    Karpf, Adam R.
    Odunsi, Kunle
    Miller, Austin
    Kocent, Justin
    Wang, Eunice S.
    Nemeth, Michael J.
    Griffiths, Elizabeth A.
    BLOOD, 2015, 126 (23)
  • [45] NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer
    Kayser, Simone
    Boss, Cristina
    Schumm, Michael
    Feucht, Judith
    Stevanovic, Stefan
    Lang, Peter
    Handgretinger, Rupert
    Garbe, Claus
    Roecken, Martin
    Feuchtinger, Tobias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients
    Valmori, D
    Dutoit, V
    Liénard, D
    Rimoldi, D
    Pittet, MJ
    Champagne, P
    Ellefsen, K
    Sahin, U
    Speiser, D
    Lejeune, F
    Cerottini, JC
    Romero, P
    CANCER RESEARCH, 2000, 60 (16) : 4499 - 4506
  • [47] The expression of NY-ESO-1, cancer specific antigen, in patients with hepatocellular carcinoma.
    Nakamura, S
    Nouso, K
    Taniyama, M
    Kobayasi, Y
    Nakatsukasa, H
    Uemura, M
    Sato, S
    Yumoto, E
    Yokoyama, J
    Tsuboi, S
    Higashi, T
    Tsuji, T
    HEPATOLOGY, 2001, 34 (04) : 180A - 180A
  • [48] Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
    Robbins, Paul F.
    Morgan, Richard A.
    Feldman, Steven A.
    Yang, James C.
    Sherry, Richard M.
    Dudley, Mark E.
    Wunderlich, John R.
    Nahvi, Azam V.
    Helman, Lee J.
    Mackall, Crystal L.
    Kammula, Udai S.
    Hughes, Marybeth S.
    Restifo, Nicholas P.
    Raffeld, Mark
    Lee, Chyi-Chia Richard
    Levy, Catherine L.
    Li, Yong F.
    El-Gamil, Mona
    Schwarz, Susan L.
    Laurencot, Carolyn
    Rosenberg, Steven A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 917 - 924
  • [49] Genetically engineered NY-ESO-1-specific T cells in HLA-A2+patients with synovial sarcoma
    Merchant, Melinda S.
    D'Angelo, Sandra P.
    Zhang, Hua
    Bernstein, Donna
    Binder-Scholl, Gwen
    Holdich, Tom
    Melchiori, Luca
    Williams, Dan
    Fortin, Marylene
    Peretz, Yoav
    Howe, Jason
    Mehler, Michael
    Hug, Bruce A.
    Wright, Matthew
    Grupp, Stephen
    Meyers, Paul A.
    Tap, William
    Jakobsen, Bent
    Mackall, Crystal L.
    CANCER RESEARCH, 2015, 75
  • [50] Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy
    Kayser, Simone
    Boss, Cristina
    Feucht, Judith
    Witte, Kai-Erik
    Scheu, Alexander
    Buelow, Hans-Joerg
    Joachim, Stefanie
    Stevanovic, Stefan
    Schumm, Michael
    Rittig, Susanne M.
    Lang, Peter
    Roecken, Martin
    Handgretinger, Rupert
    Feuchtinger, Tobias
    ONCOIMMUNOLOGY, 2015, 4 (05):
12345